发明申请
US20070027160A1 Piperazine-piperidine antagonists and agonists of the 5-HT1A receptor
失效
哌嗪 - 哌啶拮抗剂和5-HT1A受体的激动剂
- 专利标题： Piperazine-piperidine antagonists and agonists of the 5-HT1A receptor
- 专利标题（中）： 哌嗪 - 哌啶拮抗剂和5-HT1A受体的激动剂
-
申请号： US11450942申请日： 2006-06-09
-
公开(公告)号： US20070027160A1公开(公告)日： 2007-02-01
- 发明人: Magda Asselin , George Grosu , Annmarie Sabb , Wayne Childers , Lisa Havran , Zhongqi Shen , James Bicksler , Dan Chong
- 申请人： Magda Asselin , George Grosu , Annmarie Sabb , Wayne Childers , Lisa Havran , Zhongqi Shen , James Bicksler , Dan Chong
- 申请人地址： US NJ Madison
- 专利权人： Wyeth
- 当前专利权人： Wyeth
- 当前专利权人地址： US NJ Madison
- 主分类号： A61K31/496
- IPC分类号： A61K31/496 ; C07D403/14
摘要：
The present invention relates to novel piperazine-piperidine compounds. The compounds are useful as 5-HT1A binding agents, particularly as 5-HT1A receptor antagonists and agonists. These compounds are useful in treating central nervous system disorders, such as cognition disorders, anxiety disorders, depression and sexual dysfunction.